Yeast Infection, also called candidiasis, is a general type of fungal infection. Yeast infection occurs in several parts of the human body, such as the skin, oral cavity, and intestines. Vaginal yeast infection is most common and widely usual among women and is called candidal vaginitis or candidal vulvovaginitis (CVV). Candida albicans is the most usual fungus responsible for vaginal yeast infection. Yeast infection can occur due to various reasons such as unhygienic conditions, weak immunity, and a favorable environment for the growth of the related microbes, which is a key reason for market growth. Along with infants, people who have diabetes, obesity, hypothyroidism, and inflammatory disorders are also vulnerable to catching yeast infection, increasing the demand for yeast infection treatment. The global yeast infection market is further driven by the continuously rising geriatric population and an increasing number of patients suffering from HIV. The difficulties during treatments and various treatment-associated side effects are limiting the growth of the market. The Yeast Infection Market is expected to grow at the rate of 5.65% CAGR by 2027. 

Research Methodology:

The Yeast Infection Market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology and a unique balance of primary insights. The real-time valuation of the market is an integral part of our forecasting and market sizing methodology. Industry experts and our primary participants have helped to compile related aspects with accurate parametric estimations for a complete study. The primary participants share is given below:

Yeast Infection Market based on Pathogen Type

• Candida albicans
• Candida glabrata
• Candida rugosa
• Others

Yeast Infection Market based on Infection Type

• Vaginal Infection
• Throat Infection
• Skin Infection
• Esophagus Infection
• Others

Yeast Infection Market based on Treatment

• Medications
• Creams/Ointments
• Probiotics
• Others

Yeast Infection Treatment Market based on End Users

• Clinics
• Hospitals
• Ambulatory centers
• Others

Yeast Infection Market based on Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

In the market based on pathogen type, the candida Albicans is the most common fungus responsible for the yeast infection, which is the segment that holds the major share of the market. This is due to the increasing population with diabetes worldwide and increasing birth rates.

As observed in the infection type, the vaginal infection segment has the maximum share in the market. This is due to the overgrowth of candida which causes yeast infections vagina. In addition, the vaginal infection type is expected in people due to the weak immune system, stress, and lack of sleep, eventually augmenting the segment growth.

The medication segment has a major share in the yeast infection market compared to treatments. Medication is considered the effective way to get rid of yeast infection and is considered the fastest treatment. Moreover, the medication also works in preventing yeast infection.

As in the market by end-users, the hospitals' segment held the major share in the market. The key share is attributed to the increasing number of patients suffering from yeast infection and the availability of better treatments in the hospitals.

In terms of geography, North America is expected to have a major contribution to market growth. An increase in yeast infection and the number of cases of vaginal infections is a major factor propelling the market in the region. Moreover, the increasing burden of the urology patient population and advanced healthcare infrastructure are also responsible factors.

The rising number of invasive candidiasis and vaginal candidiasis incidence and premature births worldwide have a high economic burden on the patient population, as a result, augments the global yeast infection market growth. Candidemia, the common form of invasive candidiasis, is the most typical bloodstream infection, resulting in long hospital stays. Moreover, this type of infection is considered a fatal infection, increasing the demand for yeast infection treatments.

The yeast infection market report provides a few notable companies such as Astellas Pharma Inc., Brundavan Laboratories Private Limited, Synmedic Laboratories Pvt Ltd, Merck & Co., Inc., Astra Zeneca Plc, Abbott Laboratories, Allergan Plc, Bayer AG, Corden Pharma GmbH, and Pfizer Inc.

Henceforth, yeast infection treatment has a prominent role as these types of infections have increased enormously due to the shifting lifestyles of the people. Moreover, the yeast infection market is witnessing the highest growth rate as candidiasis infections increase daily.

• This report segments the yeast infection market exclusively and provides the nearest estimation of the overall market size and the sub-segments across key regions.
• This study assists shareholders in understanding the market and gives information on key market propellants, restraints, challenges, and opportunities.
• This research would also assist shareholders in identifying their competitors better and achieving more information to intensify their position in the business.
• The report also focuses on the competitive outlook, including product launches, acquisitions, mergers, and partnerships of the players.

1. Executive Summary
2. Industry Outlook
   1. Industry Overview
   2. Industry Trends
3. Market Snapshot
   1. Market Definition
   2. Market Outlook
      1. Porter Five Forces
   3. Related Markets
4. Market characteristics
   1. Market Overview
   2. Market Segmentation
   3. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
   4. DRO - Impact Analysis
5. Pathogen Type: Market Size & Analysis
   1. Overview
   2. Candida albicans
   3. Candida glabrata
   4. Candida rugosa
   5. Others
6. Infection Type: Market Size & Analysis
   1. Overview
   2. Vaginal Infection
   3. Throat Infection
   4. Skin Infection
   5. Esophagus Infection
   6. Others
7. Treatment: Market Size & Analysis
   1. Overview
   2. Medications
   3. Creams/Ointments
   4. Probiotics
   5. Others
8. End Users: Market Size & Analysis
   1. Overview
   2. Clinics
   3. Hospitals
   4. Ambulatory centers
   5. Others
9. Geography: Market Size & Analysis
   1. Overview
   2. North America
   3. Europe
   4. Asia Pacific
   5. Rest of the World
10. Competitive Landscape
    1. Competitor Comparison Analysis
    2. Market Developments
       1. Mergers and Acquisitions, Legal, Awards, Partnerships
       2. Product Launches and execution
11. Vendor Profiles
    1. Astellas Pharma Inc.
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    2. Brundavan Laboratories Private Limited
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    3. Synmedic Laboratories Pvt Ltd
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    4. Merck & Co., Inc.
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    5. Astra Zeneca Plc
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    6. Abbott Laboratories
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    7. Allergan Plc
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    8. Bayer AG
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    9. Corden Pharma GmbH
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    10. Pfizer Inc.
        1. Overview
        2. Financial Overview
        3. Product Offerings
        4. Developments
        5. Business Strategy
12. Analyst Opinion
13. Annexure
    1. Report Scope
    2. Market Definitions
    3. Research Methodology
       1. Data Collation and In-house Estimation
       2. Market Triangulation
       3. Forecasting
    4. Report Assumptions
    5. Declarations
    6. Stakeholders
    7. Abbreviations